Search Results - "Chervontseva, A M"

Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience by Baryakh, E A, Tyurina, N G, Vorobyev, V I, Gemdzhyan, E G, Mangasarova, Ya K, Klyasova, G A, Kovrigina, A M, Obukhova, T N, Zvonkov, E E, Vernyuk, M A, Chervontseva, A M, Polyakov, Yu Yu, Misyurina, А Е, Valiev, T T, Zherebtsova, V A, Magomedova, A U, Galstyan, G M, Yatskov, K V, Nesterova, E S, Vorobyev, A I, Kravchenko, S K

“…To evaluate the efficiency and toxicity of the intensive Burkitt's lymphoma (BL) therapy protocol BL-M-04. A total of 70 patients diagnosed with BL, including…”
Get full text

Immunochemotherapy of refractory classical Hodgkin's lymphoma with high-dose consolidation and autologous hematopoietic stem cell transplantation complicated by a new coronavirus infection by Khayrullina, L. S., Vernyuk, M. A., Chervontseva, A. M., Cherkashina, I. V., Gushchina, E. E., Fedenko, A. A.

“…Classical Hodgkin's lymphoma is one of the most treatable lymphoproliferative diseases with current chemotherapy regimens. The 5-year overall survival rate…”
Get full text

Early progression of follicular lymphoma: a view of the problem and personal experience by Vernyuk, M. A., Chervontseva, A. M., Cherkashina, I. V., Gushchina, E. E., Khayrullina, L. S., Fedenko, A. A.

“…Follicular lymphoma (FL) refers to indolent mature B-cell lymphomas and, despite the recurrent course, is generally characterized by a favorable prognosis with…”
Get full text

EXPERIENCE IN THE TREATMENT OF REFRACTORY HODGKIN’S LYMPHOMA by Chervontseva, A. M., Verniuk, M. A., Gushchina, E. E., Cherkashina, I. V., Fedenko, A. A.

“…Background. The use of modern induction chemotherapy programs for primary Hodgkin’s lymphoma allows achievement of high long-term outcomes even in patients…”
Get full text

Treatment of primary central nervous system lymphomas by Cherkashina, I. V., Vernyuk, M. A., Chervontseva, A. M., Gushchina, E. E., Khayrullina, L. S., Lunin, V. V., Zeynalova, P. A., Fedenko, A. A.

“…Primary lymphoma of the central nervous system (PLCNS) is a rare form of extranodal lymphoma characterized by an aggressive course. In recent decades, the…”
Get full text

Comparative evaluation of the effectiveness of primary treatment regimens in patients with classical Hodgkin’s lymphoma from the group of unfavorable prognosis by Chervontseva, A. M., Verniuk, M. A., Gushchina, E. E., Cherkashina, I. V., Pavlova, O. A., Khayrullina, L. S., Fedenko, А. А.

“…Objective . Comparative evaluation of the effectiveness and toxicity profile of intensified chemotherapy regimens BEACOPP escalated (esc.), BEACOPP-14 and…”
Get full text

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2nd line treatment before autologous hematopoietic stem cell transplantation (preliminary results) by Mamedova, A. A., Mochkin, N. E., Sarzhevskiy, V. O., Demina, E. A., Bogatyrev, V. S., Spornik, A. A., Samoylova, A. A., Rukavitsin, A. A., Smirnova, E. G., Bannikova, A. E., Melnichenko, V. Ya, Mikhaylova, N. B., Borzenkova, E. S., Stelmakh, L. V., Zalyalov, Yu. R., Semenova, A. A., Tumyan, G. S., Danilova, M. A., Konova, O. A., Falaleeva, N. A., Terekhova, A. Yu, Vernyuk, M. A., Chervontseva, A. M., Khayrullina, L. S., Maslov, A. A., Lysenko, I. B., Alekseeva, Yu. A., Pavlyuchenko, E. S., Mirsaitov, A. A., Zverkova, A. A., Ishmatova, I. V., Volchenkov, S. A., Motalkina, M. S., Zyuzgin, I. S.

“…Aim . To study the efficacy and safety of combined immunochemotherapy according to the DHAp protocol + nivolumab in patients with refractory/relapsed classical…”
Get full text

Damage of vascular endothelium in the treatment of acute leukemia: in vitro study by Romanov, Iu A, Chervontseva, A M, Savchenko, V G

“…Cytostatic drugs used in the treatment of hemopoietic malignancies affect cells of other organs and systems, vascular endothelium, in particular. This leads to…”
Get more information

Own experience of primary mediastinal B-large cell lymphoma treatment by M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov

“…Due to the relative low incidence of primary mediastinal B-large cell lymphoma (PM BLCL) optimal approaches to its treatment is still not well developed…”
Get full text

Own experience of primary mediastinal B-large cell lymphoma treatment by M. A. Vernyuk, N. G. Tyurina, O. A. Pavlova, A. M. Chervontseva, N. V. Zhukov

“…Due to the relative low incidence of primary mediastinal B-large cell lymphoma (PM BLCL) optimal approaches to its treatment is still not well developed…”
Get full text

Effect of cytarabine on expression of cell adhesion molecules and on endothelium-leukocyte interaction in vitro by Chervontseva, A M, Romanov, Iu A, Savchenko, V G

“…To characterize cytarabine effects on human endothelium expression of cell adhesion molecules (CAM) of various classes and interaction of cultured endothelial…”
Get more information

Damage to vascular endothelium in the treatment of acute leukemia: in vitro study by Yu A Romanov, A M Chervontseva, V G Savchenko

“…Aim. Cytostatic drugs used in the treatment of hemopoietic malignancies affect cells of other organs and systems, vascular endothelium, in particular. This…”
Get full text